Company intelligence / Profile preview

Braingaze

Ownership: Private
Employees: ~15
Development stage: Commercial

Overview

Braingaze has developed CE-marked, patented digital diagnostic tools with up to ~92% accuracy for ADHD diagnosis using involuntary eye movement biomarkers. The company’s solutions are used in clinics across Europe and have been validated against DSM‑5/ICD‑11 criteria. Therapeutic products are being clinically developed to improve cognitive function in ADHD, ASD, dyslexia, and Alzheimer’s disease. A major US licensing deal with Tris Pharma was signed in April 2024.

Therapeutic areas: PsychiatryNeurology
Modalities: Device (eye-tracking diagnostic tool)Non-pharmacological therapy (digital therapeutic games)Digital biomarker-based technologyArtificial intelligence-based diagnostics and therapeutics
Industry: Digital Health Medical Devices

Partnerships

Tris Pharma—exclusive licensee/commercialization partner for the US & Canada digital ADHD diagnostic platform

Beyond the preview

Go deeper on Braingaze.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Braingaze.

Explore the full profile